122 related articles for article (PubMed ID: 36999340)
21. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
[TBL] [Abstract][Full Text] [Related]
22. [Impact of first-line chemotherapy on renal function in patients with advanced upper tract urothelial carcinoma].
Li X; Sheng XN; Chi ZH; Cui CL; Si L; Mao LL; Tang BX; Lian B; Wang X; Yan XQ; Li SM; Bai X; Zhou L; Kong Y; Dai J; Guo J
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2574-2578. PubMed ID: 30220142
[No Abstract] [Full Text] [Related]
23. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
Liedberg F; Hagberg O; Aljabery F; Gårdmark T; Jahnson S; Jerlström T; Ströck V; Söderkvist K; Ullén A; Bobjer J
Scand J Urol; 2024 Jan; 59():19-25. PubMed ID: 38226846
[TBL] [Abstract][Full Text] [Related]
25. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion.
Rao K; Manya K; Azad A; Lawrentschuk N; Bolton D; Davis ID; Sengupta S
BJU Int; 2014 Nov; 114 Suppl 1():50-4. PubMed ID: 25070295
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?
Trail M; Rahman MSW; Broadhurst WJ; Blackmur JP; Sharma A; Chew E; O'Donnell M; Keanie JY; Brush J; Taylor J; Phipps S; Thomas B; Mains EAA; McNeill SA; Leung S; Cutress ML; Laird A
BJU Int; 2023 Jun; 131(6):755-762. PubMed ID: 36495480
[TBL] [Abstract][Full Text] [Related]
27. Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study.
Lin T; Pham J; Paul E; Conron M; Wright G; Ball D; Mitchell P; Atkin N; Brand M; Zalcberg J; Stirling RG
Lung Cancer; 2022 Jan; 163():69-76. PubMed ID: 34923204
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
Morizane S; Yumioka T; Yamaguchi N; Masago T; Honda M; Sejima T; Takenaka A
Int Urol Nephrol; 2015 Aug; 47(8):1335-41. PubMed ID: 26104379
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
30. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
[TBL] [Abstract][Full Text] [Related]
31. Impacts of multidisciplinary meeting case discussion on palliative care referral and end-of-life care in lung cancer: a retrospective observational study.
Sridharan K; Paul E; Stirling RG; Li C
Intern Med J; 2021 Sep; 51(9):1450-1456. PubMed ID: 33463032
[TBL] [Abstract][Full Text] [Related]
32. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H;
Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969
[TBL] [Abstract][Full Text] [Related]
33. Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy.
Lee KH; Chen YT; Chung HJ; Liu JS; Hsu CC; Tarng DC
Ren Fail; 2016; 38(1):77-83. PubMed ID: 26513686
[TBL] [Abstract][Full Text] [Related]
34. Genomic Characterization of Upper Tract Urothelial Carcinoma.
Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
[TBL] [Abstract][Full Text] [Related]
35. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
Kates M; Badalato GM; Gupta M; McKiernan JM
BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
[TBL] [Abstract][Full Text] [Related]
36. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
37. Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.
Kao YL; Yang WH; Ou CH
Int Urol Nephrol; 2022 Jan; 54(1):63-69. PubMed ID: 34783981
[TBL] [Abstract][Full Text] [Related]
38. Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma.
Zhao H; Liu K; Giannakopoulos S; Yuruk E; De Naeyer G; Álvarez-Maestro M; Ng CF; Laguna P; De La Rosette J; Yuen-Chun Teoh J
BMC Urol; 2023 Mar; 23(1):49. PubMed ID: 36991375
[TBL] [Abstract][Full Text] [Related]
39. Endophytic upper tract urothelial carcinoma in a solitary kidney treated by cryotherapy: an unorthodox case for successful management.
Abdelaziz A; Sultan M; Hammad MA; Martinez JR; Yacoub M; Youssef RF
BMC Urol; 2023 Jun; 23(1):111. PubMed ID: 37370049
[TBL] [Abstract][Full Text] [Related]
40. Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.
Wu YT; Luo HL; Wang HJ; Chen YT; Cheng YT; Chiang PH
Int Urol Nephrol; 2020 Jun; 52(6):1043-1048. PubMed ID: 31997062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
